Collaboration between Dialysis Providers
J Am Soc Nephrol
.
2022 Aug;33(8):1440-1444.
doi: 10.1681/ASN.2021111475.
Epub 2022 Jun 2.
Authors
Jeffrey Silberzweig
1
2
,
J Ganesh Bhat
3
4
,
Mary O Dittrich
5
,
Raghu Durvasula
6
,
Jeff Giullian
7
,
Jeffrey L Hymes
8
,
Doug Johnson
9
,
Brigitte Schiller
10
11
,
Richard Spech
12
,
Leslie Spry
13
,
Geoffrey Scott Walker
14
,
Suzanne Watnick
15
16
,
Jerry Yee
17
18
,
Barry I Freedman
19
20
Affiliations
1
The Rogosin Institute, New York, New York.
2
Department of Medicine, Weill Cornell Medical College, New York, New York.
3
Atlantic Dialysis Management Services, New York, New York.
4
Xavier University School of Medicine, Oranjestad, Aruba.
5
US Renal Care, Plano, Texas.
6
Puget Sound Kidney Centers, Everett, Washington.
7
DaVita, Inc., Denver, Colorado.
8
Fresenius Kidney Care, Waltham, Massachusetts.
9
Dialysis Clinic, Inc., Nashville, Tennessee.
10
Satellite Healthcare, San Jose, California.
11
Division of Nephrology, Stanford University, Palo Alto, California.
12
Centers for Dialysis Care, Cleveland, Ohio.
13
Dialysis Centers of Lincoln, Lincoln, Nebraska.
14
Medical Advisory Committee, American Renal Associates, Beverly, Massachusetts.
15
Northwest Kidney Centers, Seattle, Washington.
16
University of Washington, Seattle, Washington.
17
Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan.
18
Greenfield Health Systems, Detroit, Michigan.
19
Health Systems Management, Inc., Tifton, Georgia.
20
Internal Medicine/Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
PMID:
35654601
PMCID:
PMC9342651
DOI:
10.1681/ASN.2021111475
No abstract available
Keywords:
COVID-19; dialysis; end stage kidney disease; outcomes; patient-centered care.
MeSH terms
Humans
Kidney Failure, Chronic* / therapy
Renal Dialysis*